Helen of Troy Limited Reports Fourth Quarter Fiscal 2025 Results
Consolidated Net Sales Decline of 0.7%
GAAP Diluted EPS Growth of 24.0% to
Adjusted Diluted EPS Decline of 4.9% to
Cash Flow from Operations of
Executive Summary – Fourth Quarter of Fiscal 2025 Compared to Fiscal 2024
-
Consolidated net sales revenue of
$485.9 million compared to$489.2 million
- Gross profit margin of 48.6% compared to 49.0%
-
Operating margin of 0.4%, which includes non-cash asset impairment charges of
$51.5 million , compared to 13.5%
- Non-GAAP adjusted operating margin of 15.4% compared to 17.0%
-
GAAP diluted EPS of
$2.22 compared to$1.79
-
Non-GAAP adjusted diluted EPS of
$2.33 compared to$2.45
-
Net cash provided by operating activities of
$35.0 million compared to$73.6 million
- Non-GAAP adjusted EBITDA margin of 17.4% compared to 19.3%
Executive Summary - Fiscal 2025 Compared to Fiscal 2024
-
Consolidated net sales revenue of
$1.908 billion , a decrease of 4.9%
- Gross profit margin improvement of 60 basis points to 47.9% compared to 47.3%
- Operating margin of 7.5% compared to 13.0%
- Non-GAAP adjusted operating margin of 13.2% compared to 15.0%
-
GAAP diluted EPS of
$5.37 compared to$7.03
-
Non-GAAP adjusted diluted EPS of
$7.17 compared to$8.91
-
Net cash provided by operating activities of
$113.2 million compared to$306.1 million
- Non-GAAP adjusted EBITDA margin of 15.2% compared to 16.8%
Ms.
|
Three Months Ended Last Day of February, |
||||||||||
(in thousands) (unaudited) |
Home &
|
|
Beauty &
|
|
Total |
||||||
Fiscal 2024 sales revenue, net |
$ |
223,312 |
|
|
$ |
265,889 |
|
|
$ |
489,201 |
|
Organic business (4) |
|
(2,700 |
) |
|
|
(21,157 |
) |
|
|
(23,857 |
) |
Impact of foreign currency |
|
(793 |
) |
|
|
(1,670 |
) |
|
|
(2,463 |
) |
Acquisition (5) |
|
— |
|
|
|
23,010 |
|
|
|
23,010 |
|
Change in sales revenue, net |
|
(3,493 |
) |
|
|
183 |
|
|
|
(3,310 |
) |
Fiscal 2025 sales revenue, net |
$ |
219,819 |
|
|
$ |
266,072 |
|
|
$ |
485,891 |
|
|
|
|
|
|
|
||||||
Total net sales revenue growth (decline) |
|
(1.6 |
)% |
|
|
0.1 |
% |
|
|
(0.7 |
)% |
Organic business |
|
(1.2 |
)% |
|
|
(8.0 |
)% |
|
|
(4.9 |
)% |
Impact of foreign currency |
|
(0.4 |
)% |
|
|
(0.6 |
)% |
|
|
(0.5 |
)% |
Acquisition |
|
— |
% |
|
|
8.7 |
% |
|
|
4.7 |
% |
|
|
|
|
|
|
||||||
Operating margin (GAAP) |
|
|
|
|
|
||||||
Fiscal 2025 |
|
14.7 |
% |
|
|
(11.4 |
)% |
|
|
0.4 |
% |
Fiscal 2024 |
|
15.7 |
% |
|
|
11.7 |
% |
|
|
13.5 |
% |
Adjusted operating margin (non-GAAP) (1) |
|
|
|
|
|
||||||
Fiscal 2025 |
|
17.9 |
% |
|
|
13.4 |
% |
|
|
15.4 |
% |
Fiscal 2024 |
|
18.7 |
% |
|
|
15.6 |
% |
|
|
17.0 |
% |
Consolidated Results - Fourth Quarter Fiscal 2025 Compared to Fourth Quarter Fiscal 2024
-
Consolidated net sales revenue decreased
$3.3 million , or 0.7%, to$485.9 million , compared to$489.2 million , primarily driven by a decrease from Organic business of$23.9 million , or 4.9%. The Organic business decrease was due to a decline in Beauty & Wellness primarily driven by lower Beauty hair appliance sales and a decline in Home & Outdoor primarily resulting from a decline in insulated beverageware sales. The Organic business decline was partially offset by the contribution from the acquisition ofOlive & June, LLC (“Olive & June”) of$23.0 million , or 4.7%, to consolidated net sales revenue.
- Consolidated gross profit margin decreased 40 basis points to 48.6%, compared to 49.0%. The decrease was primarily due to a less favorable product mix within the segments and a less favorable customer mix within Home & Outdoor. These factors were partially offset by favorable inventory obsolescence expense and lower commodity and product costs, partly driven by Project Pegasus initiatives.
- Consolidated selling, general and administrative expense (“SG&A”) ratio increased 120 basis points to 35.9%, compared to 34.7%. The increase was primarily due to acquisition-related expenses incurred in connection with the Olive & June transaction and higher marketing expense as the Company reinvested back into its brands. These factors were partially offset by lower overall personnel expense, primarily driven by lower annual incentive and share-based compensation expenses.
-
The Company recognized non-cash asset impairment charges of
$51.5 million ($47.6 million after tax), during the fourth quarter of fiscal 2025, to reduce the goodwill and definite-lived trade name of itsDrybar business, which is included within Beauty & Wellness.
-
Consolidated operating income was
$2.0 million , or 0.4% of net sales revenue, compared to$66.2 million , or 13.5% of net sales revenue. The decrease in consolidated operating margin was primarily due to non-cash asset impairment charges of$51.5 million , higher restructuring charges, an increase in the aforementioned consolidated SG&A ratio, and a decrease in consolidated gross profit margin.
-
Interest expense was
$14.0 million , compared to$12.5 million . The increase in interest expense was primarily due to higher average borrowings outstanding, including borrowings to fund the acquisition of Olive & June.
-
Income tax benefit was
$62.5 million , compared to income tax expense of$12.0 million , primarily due to a transitional tax benefit of$64.6 million resulting from the Company's intangible asset reorganization(6) recognized during the fourth quarter of fiscal 2025, partially offset by shifts in the mix of income in various tax jurisdictions.
-
Net income was
$50.9 million , compared to$42.7 million . Diluted EPS was$2.22 , compared to$1.79 . Diluted EPS increased primarily due to a$64.6 million transitional income tax benefit recognized in connection with the Company's intangible asset reorganization and lower weighted average diluted shares outstanding, partially offset by lower operating income inclusive of after-tax non-cash asset impairment charges of$47.6 million .
-
Non-GAAP adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) decreased 10.6% to
$84.3 million , compared to$94.3 million . Non-GAAP adjusted EBITDA margin was 17.4%, compared to 19.3%.
On an adjusted basis (non-GAAP) for the fourth quarters of fiscal 2025 and 2024, excluding acquisition-related expenses, asset impairment charges(7), intangible asset reorganization, restructuring charges, amortization of intangible assets, and non-cash share-based compensation, as applicable:
-
Adjusted operating income decreased
$8.2 million , or 9.9%, to$75.0 million , or 15.4% of net sales revenue, compared to$83.3 million , or 17.0% of net sales revenue. The 160 basis point decrease in adjusted operating margin was primarily driven by higher marketing expense, a less favorable product mix within the segments and a less favorable customer mix within Home & Outdoor. These factors were partially offset by favorable inventory obsolescence expense, lower commodity and product costs, partly driven by Project Pegasus initiatives, and lower annual incentive compensation.
-
Adjusted income decreased
$5.2 million , or 8.8%, to$53.4 million , compared to$58.6 million . Adjusted diluted EPS decreased 4.9% to$2.33 , which includes an unfavorable impact from foreign currency of approximately$0.11 , compared to$2.45 . The year-over-year decrease in adjusted diluted EPS was primarily due to lower adjusted operating income and higher interest expense, partially offset by a decrease in the adjusted effective income tax rate and lower weighted average diluted shares outstanding.
Segment Results - Fourth Quarter Fiscal 2025 Compared to Fourth Quarter Fiscal 2024
Home & Outdoor net sales revenue decreased
Home & Outdoor operating income was
Beauty & Wellness net sales revenue increased
Beauty & Wellness operating loss was
Balance Sheet and Cash Flow - Fiscal 2025 Compared to Fiscal 2024
-
Cash and cash equivalents totaled
$18.9 million , compared to$18.5 million .
- Accounts receivable turnover(8) was 71.5 days, compared to 66.2 days.
-
Inventory was
$452.6 million , compared to$396.0 million .
-
Total short- and long-term debt was
$916.9 million , compared to$665.7 million .
-
Net cash provided by operating activities for fiscal 2025 was
$113.2 million , compared to$306.1 million .
-
Free cash flow(1)(2) for fiscal 2025 was
$83.1 million , compared to$269.4 million .
Pegasus Restructuring Plan
The Company previously announced a global restructuring plan intended to expand operating margins through initiatives designed to improve efficiency and effectiveness and reduce costs (collectively referred to as “Project Pegasus”). Project Pegasus includes multiple workstreams to further optimize the Company's brand portfolio, streamline and simplify the organization, accelerate and amplify cost of goods savings projects, enhance the efficiency of its supply chain network, optimize its indirect spending and improve its cash flow and working capital, as well as other activities. These initiatives have created operating efficiencies, as well as provided a platform to fund growth investments.
During the fourth quarter of fiscal 2025, the Company completed Project Pegasus, which resulted in total pre-tax restructuring charges of
The Company continues to have the following expectations regarding Project Pegasus savings:
-
Targeted annualized pre-tax operating profit improvements of approximately
$75 million to$85 million , which began in fiscal 2024 and are expected to be substantially achieved by the end of fiscal 2027.
- Estimated cadence of the recognition of the savings will be approximately 25% and 35% in fiscal 2024 and 2025, respectively, which were both achieved, and approximately 25% and 15% in fiscal 2026 and 2027, respectively.
- Total profit improvements to be realized approximately 60% through reduced cost of goods sold and 40% through lower SG&A.
Fiscal 2026 Business Update
Due to evolving global tariff policies and the related business and macroeconomic uncertainty, the Company is not providing an outlook for fiscal 2026 at this time. The Company is in the process of assessing the incremental tariff impact in light of continuing changes to global tariff policies, and the full extent of its potential mitigation plans, as well as the associated timing to fully execute such plans in a rapidly changing macro environment. To mitigate the Company's risk of ongoing exposure to tariffs, it has intensified efforts to diversify its production outside of
Out of an abundance of caution and in expectation of a difficult and uncertain environment, the Company is implementing a number of measures to reduce costs and preserve cash flow that will remain in place until there is greater certainty and less variability, which include the following:
- Suspension of projects and capital expenditures that are not critical or in support of supplier diversification or dual sourcing initiatives;
- Reduction and deferral of marketing, promotional, and new product development expense;
- Actions to reduce overall personnel costs and pause most project and travel expenses;
-
A freeze on inventory purchases from
China in the short term, with the exception of purchases supporting key launches already underway, and an overall reduction in inventory purchases in expectation of softer consumer demand in the short to intermediate term; and
- Actions to optimize accounts receivable and payable days outstanding.
Through the combination of tariff mitigation actions and these additional cost reduction measures, the Company believes it can offset 70% to 80% of the tariff impact in fiscal 2026, based on tariffs currently in place.
Conference Call and Webcast
The Company will conduct a teleconference in conjunction with today's earnings release. The teleconference begins at
Non-GAAP Financial Measures
The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in
About
For more information about Helen of Troy, please visit http://investor.helenoftroy.com
Forward-Looking Statements
Certain written and oral statements made by the Company and subsidiaries of the Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this press release, in other filings with the
HELEN OF TROY LIMITED AND SUBSIDIARIES |
||||||||||||
Consolidated Statements of Income (5) |
||||||||||||
(Unaudited) (in thousands, except per share data) |
||||||||||||
|
Three Months Ended Last Day of February, |
|||||||||||
|
2025 |
|
2024 |
|||||||||
Sales revenue, net |
$ |
485,891 |
|
|
100.0 |
% |
|
$ |
489,201 |
|
100.0 |
% |
Cost of goods sold |
|
249,962 |
|
|
51.4 |
% |
|
|
249,606 |
|
51.0 |
% |
Gross profit |
|
235,929 |
|
|
48.6 |
% |
|
|
239,595 |
|
49.0 |
% |
Selling, general and administrative expense (“SG&A”) |
|
174,516 |
|
|
35.9 |
% |
|
|
169,569 |
|
34.7 |
% |
Asset impairment charges |
|
51,455 |
|
|
10.6 |
% |
|
|
— |
|
— |
% |
Restructuring charges |
|
7,943 |
|
|
1.6 |
% |
|
|
3,850 |
|
0.8 |
% |
Operating income |
|
2,015 |
|
|
0.4 |
% |
|
|
66,176 |
|
13.5 |
% |
Non-operating income, net |
|
370 |
|
|
0.1 |
% |
|
|
1,053 |
|
0.2 |
% |
Interest expense |
|
13,999 |
|
|
2.9 |
% |
|
|
12,500 |
|
2.6 |
% |
(Loss) income before income tax |
|
(11,614 |
) |
|
(2.4 |
)% |
|
|
54,729 |
|
11.2 |
% |
Income tax (benefit) expense |
|
(62,531 |
) |
|
(12.9 |
)% |
|
|
11,995 |
|
2.5 |
% |
Net income |
$ |
50,917 |
|
|
10.5 |
% |
|
$ |
42,734 |
|
8.7 |
% |
|
|
|
|
|
|
|
|
|||||
Diluted earnings per share (“EPS”) |
$ |
2.22 |
|
|
|
|
$ |
1.79 |
|
|
||
|
|
|
|
|
|
|
|
|||||
Weighted average shares of common stock used in computing diluted EPS |
|
22,904 |
|
|
|
|
|
23,891 |
|
|
|
Fiscal Years Ended Last Day of February, |
|||||||||||
|
2025 |
|
2024 |
|||||||||
Sales revenue, net |
$ |
1,907,665 |
|
|
100.0 |
% |
|
$ |
2,005,050 |
|
100.0 |
% |
Cost of goods sold |
|
993,259 |
|
|
52.1 |
% |
|
|
1,056,390 |
|
52.7 |
% |
Gross profit |
|
914,406 |
|
|
47.9 |
% |
|
|
948,660 |
|
47.3 |
% |
SG&A |
|
705,381 |
|
|
37.0 |
% |
|
|
669,359 |
|
33.4 |
% |
Asset impairment charges |
|
51,455 |
|
|
2.7 |
% |
|
|
— |
|
— |
% |
Restructuring charges |
|
14,822 |
|
|
0.8 |
% |
|
|
18,712 |
|
0.9 |
% |
Operating income |
|
142,748 |
|
|
7.5 |
% |
|
|
260,589 |
|
13.0 |
% |
Non-operating income, net |
|
838 |
|
|
— |
% |
|
|
1,518 |
|
0.1 |
% |
Interest expense |
|
51,922 |
|
|
2.7 |
% |
|
|
53,065 |
|
2.6 |
% |
Income before income tax |
|
91,664 |
|
|
4.8 |
% |
|
|
209,042 |
|
10.4 |
% |
Income tax (benefit) expense |
|
(32,087 |
) |
|
(1.7 |
)% |
|
|
40,448 |
|
2.0 |
% |
Net income |
$ |
123,751 |
|
|
6.5 |
% |
|
$ |
168,594 |
|
8.4 |
% |
|
|
|
|
|
|
|
|
|||||
Diluted EPS |
$ |
5.37 |
|
|
|
|
$ |
7.03 |
|
|
||
|
|
|
|
|
|
|
|
|||||
Weighted average shares of common stock used in computing diluted EPS |
|
23,065 |
|
|
|
|
|
23,970 |
|
|
Consolidated Net Sales Revenue by |
|||||||||||
(Unaudited) (in thousands) |
|||||||||||
|
Three Months Ended Last Day of February, |
||||||||||
|
2025 |
|
2024 |
||||||||
Domestic sales revenue, net |
$ |
372,282 |
|
76.6 |
% |
|
$ |
384,066 |
|
78.5 |
% |
International sales revenue, net |
|
113,609 |
|
23.4 |
% |
|
|
105,135 |
|
21.5 |
% |
Total sales revenue, net |
$ |
485,891 |
|
100.0 |
% |
|
$ |
489,201 |
|
100.0 |
% |
|
Fiscal Years Ended Last Day of February, |
||||||||||
|
2025 |
|
2024 |
||||||||
Domestic sales revenue, net |
$ |
1,439,251 |
|
75.4 |
% |
|
$ |
1,560,256 |
|
77.8 |
% |
International sales revenue, net |
|
468,414 |
|
24.6 |
% |
|
|
444,794 |
|
22.2 |
% |
Total sales revenue, net |
$ |
1,907,665 |
|
100.0 |
% |
|
$ |
2,005,050 |
|
100.0 |
% |
Reconciliation of Non-GAAP Financial Measures – GAAP Operating Income (Loss) and Operating Margin to Adjusted Operating Income and Adjusted Operating Margin (Non-GAAP) (1) |
||||||||||||||||||
(Unaudited) (in thousands) |
||||||||||||||||||
|
Three Months Ended |
|||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
|||||||||||||
Operating income (loss), as reported (GAAP) |
$ |
32,286 |
|
14.7 |
% |
|
$ |
(30,271 |
) |
|
(11.4 |
)% |
|
$ |
2,015 |
|
0.4 |
% |
Acquisition-related expenses |
|
— |
|
— |
% |
|
|
3,035 |
|
|
1.1 |
% |
|
|
3,035 |
|
0.6 |
% |
Asset impairment charges (7) |
|
— |
|
— |
% |
|
|
51,455 |
|
|
19.3 |
% |
|
|
51,455 |
|
10.6 |
% |
Restructuring charges |
|
3,127 |
|
1.4 |
% |
|
|
4,816 |
|
|
1.8 |
% |
|
|
7,943 |
|
1.6 |
% |
Subtotal |
|
35,413 |
|
16.1 |
% |
|
|
29,035 |
|
|
10.9 |
% |
|
|
64,448 |
|
13.3 |
% |
Amortization of intangible assets |
|
1,761 |
|
0.8 |
% |
|
|
3,508 |
|
|
1.3 |
% |
|
|
5,269 |
|
1.1 |
% |
Non-cash share-based compensation |
|
2,099 |
|
1.0 |
% |
|
|
3,227 |
|
|
1.2 |
% |
|
|
5,326 |
|
1.1 |
% |
Adjusted operating income (non-GAAP) |
$ |
39,273 |
|
17.9 |
% |
|
$ |
35,770 |
|
|
13.4 |
% |
|
$ |
75,043 |
|
15.4 |
% |
|
Three Months Ended |
|||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
|||||||||||||
Operating income, as reported (GAAP) |
$ |
35,003 |
|
15.7 |
% |
|
$ |
31,173 |
|
11.7 |
% |
|
$ |
66,176 |
|
13.5 |
% |
|
Restructuring charges |
|
500 |
|
0.2 |
% |
|
|
3,350 |
|
1.3 |
% |
|
|
3,850 |
|
0.8 |
% |
|
Subtotal |
|
35,503 |
|
15.9 |
% |
|
|
34,523 |
|
13.0 |
% |
|
|
70,026 |
|
14.3 |
% |
|
Amortization of intangible assets |
|
1,735 |
|
0.8 |
% |
|
|
2,732 |
|
1.0 |
% |
|
|
4,467 |
|
0.9 |
% |
|
Non-cash share-based compensation |
|
4,473 |
|
2.0 |
% |
|
|
4,294 |
|
1.6 |
% |
|
|
8,767 |
|
1.8 |
% |
|
Adjusted operating income (non-GAAP) |
$ |
41,711 |
|
18.7 |
% |
|
$ |
41,549 |
|
15.6 |
% |
|
$ |
83,260 |
|
17.0 |
% |
|
Fiscal Year Ended |
|||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
|||||||||||||
Operating income, as reported (GAAP) |
$ |
119,601 |
|
13.2 |
% |
|
$ |
23,147 |
|
2.3 |
% |
|
$ |
142,748 |
|
7.5 |
% |
|
Acquisition-related expenses |
|
— |
|
— |
% |
|
|
3,035 |
|
0.3 |
% |
|
|
3,035 |
|
0.2 |
% |
|
Asset impairment charges |
|
— |
|
— |
% |
|
|
51,455 |
|
5.1 |
% |
|
|
51,455 |
|
2.7 |
% |
|
Restructuring charges |
|
4,855 |
|
0.5 |
% |
|
|
9,967 |
|
1.0 |
% |
|
|
14,822 |
|
0.8 |
% |
|
Subtotal |
|
124,456 |
|
13.7 |
% |
|
|
87,604 |
|
8.7 |
% |
|
|
212,060 |
|
11.1 |
% |
|
Amortization of intangible assets |
|
7,064 |
|
0.8 |
% |
|
|
11,811 |
|
1.2 |
% |
|
|
18,875 |
|
1.0 |
% |
|
Non-cash share-based compensation |
|
10,402 |
|
1.1 |
% |
|
|
10,974 |
|
1.1 |
% |
|
|
21,376 |
|
1.1 |
% |
|
Adjusted operating income (non-GAAP) |
$ |
141,922 |
|
15.7 |
% |
|
$ |
110,389 |
|
11.0 |
% |
|
$ |
252,311 |
|
13.2 |
% |
|
Fiscal Year Ended |
|||||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
|||||||||||||||
Operating income, as reported (GAAP) |
$ |
142,732 |
|
|
15.6 |
% |
|
$ |
117,857 |
|
|
10.8 |
% |
|
$ |
260,589 |
|
|
13.0 |
% |
Bed, Bath & Beyond bankruptcy (10) |
|
3,087 |
|
|
0.3 |
% |
|
|
1,126 |
|
|
0.1 |
% |
|
|
4,213 |
|
|
0.2 |
% |
Gain on sale of distribution and office facilities (11) |
|
(16,175 |
) |
|
(1.8 |
)% |
|
|
(18,015 |
) |
|
(1.7 |
)% |
|
|
(34,190 |
) |
|
(1.7 |
)% |
Restructuring charges |
|
5,144 |
|
|
0.6 |
% |
|
|
13,568 |
|
|
1.2 |
% |
|
|
18,712 |
|
|
0.9 |
% |
Subtotal |
|
134,788 |
|
|
14.7 |
% |
|
|
114,536 |
|
|
10.5 |
% |
|
|
249,324 |
|
|
12.4 |
% |
Amortization of intangible assets |
|
7,057 |
|
|
0.8 |
% |
|
|
11,269 |
|
|
1.0 |
% |
|
|
18,326 |
|
|
0.9 |
% |
Non-cash share-based compensation |
|
16,319 |
|
|
1.8 |
% |
|
|
17,553 |
|
|
1.6 |
% |
|
|
33,872 |
|
|
1.7 |
% |
Adjusted operating income (non-GAAP) |
$ |
158,164 |
|
|
17.3 |
% |
|
$ |
143,358 |
|
|
13.2 |
% |
|
$ |
301,522 |
|
|
15.0 |
% |
Reconciliation of Non-GAAP Financial Measures – GAAP Operating Income (Loss) to EBITDA (Earnings (Loss) Before Interest, Taxes, Depreciation and Amortization), Adjusted EBITDA and Adjusted EBITDA Margin (Non-GAAP) (1) |
||||||||||||||||||
(Unaudited) (in thousands) |
||||||||||||||||||
|
Three Months Ended |
|||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
|||||||||||||
Operating income (loss), as reported (GAAP) |
$ |
32,286 |
|
14.7 |
% |
|
$ |
(30,271 |
) |
|
(11.4 |
)% |
|
$ |
2,015 |
|
0.4 |
% |
Depreciation and amortization |
|
6,515 |
|
3.0 |
% |
|
|
7,683 |
|
|
2.9 |
% |
|
|
14,198 |
|
2.9 |
% |
Non-operating income, net |
|
— |
|
— |
% |
|
|
370 |
|
|
0.1 |
% |
|
|
370 |
|
0.1 |
% |
EBITDA (non-GAAP) |
|
38,801 |
|
17.7 |
% |
|
|
(22,218 |
) |
|
(8.4 |
)% |
|
|
16,583 |
|
3.4 |
% |
Add: Acquisition-related expenses |
|
— |
|
— |
% |
|
|
3,035 |
|
|
1.1 |
% |
|
|
3,035 |
|
0.6 |
% |
Asset impairment charges |
|
— |
|
— |
% |
|
|
51,455 |
|
|
19.3 |
% |
|
|
51,455 |
|
10.6 |
% |
Restructuring charges |
|
3,127 |
|
1.4 |
% |
|
|
4,816 |
|
|
1.8 |
% |
|
|
7,943 |
|
1.6 |
% |
Non-cash share-based compensation |
|
2,099 |
|
1.0 |
% |
|
|
3,227 |
|
|
1.2 |
% |
|
|
5,326 |
|
1.1 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
44,027 |
|
20.0 |
% |
|
$ |
40,315 |
|
|
15.2 |
% |
|
$ |
84,342 |
|
17.4 |
% |
|
Three Months Ended |
||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
||||||||||||
Operating income, as reported (GAAP) |
$ |
35,003 |
|
15.7 |
% |
|
$ |
31,173 |
|
11.7 |
% |
|
$ |
66,176 |
|
13.5 |
% |
Depreciation and amortization |
|
7,562 |
|
3.4 |
% |
|
|
6,900 |
|
2.6 |
% |
|
|
14,462 |
|
3.0 |
% |
Non-operating income, net |
|
— |
|
— |
% |
|
|
1,053 |
|
0.4 |
% |
|
|
1,053 |
|
0.2 |
% |
EBITDA (non-GAAP) |
|
42,565 |
|
19.1 |
% |
|
|
39,126 |
|
14.7 |
% |
|
|
81,691 |
|
16.7 |
% |
Add: Restructuring charges |
|
500 |
|
0.2 |
% |
|
|
3,350 |
|
1.3 |
% |
|
|
3,850 |
|
0.8 |
% |
Non-cash share-based compensation |
|
4,473 |
|
2.0 |
% |
|
|
4,294 |
|
1.6 |
% |
|
|
8,767 |
|
1.8 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
47,538 |
|
21.3 |
% |
|
$ |
46,770 |
|
17.6 |
% |
|
$ |
94,308 |
|
19.3 |
% |
|
Fiscal Year Ended |
||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
||||||||||||
Operating income, as reported (GAAP) |
$ |
119,601 |
|
13.2 |
% |
|
$ |
23,147 |
|
2.3 |
% |
|
$ |
142,748 |
|
7.5 |
% |
Depreciation and amortization |
|
26,088 |
|
2.9 |
% |
|
|
28,960 |
|
2.9 |
% |
|
|
55,048 |
|
2.9 |
% |
Non-operating income, net |
|
— |
|
— |
% |
|
|
838 |
|
0.1 |
% |
|
|
838 |
|
— |
% |
EBITDA (non-GAAP) |
|
145,689 |
|
16.1 |
% |
|
|
52,945 |
|
5.3 |
% |
|
|
198,634 |
|
10.4 |
% |
Add: Acquisition-related expenses |
|
— |
|
— |
% |
|
|
3,035 |
|
0.3 |
% |
|
|
3,035 |
|
0.2 |
% |
Asset impairment charges |
|
— |
|
— |
% |
|
|
51,455 |
|
5.1 |
% |
|
|
51,455 |
|
2.7 |
% |
Restructuring charges |
|
4,855 |
|
0.5 |
% |
|
|
9,967 |
|
1.0 |
% |
|
|
14,822 |
|
0.8 |
% |
Non-cash share-based compensation |
|
10,402 |
|
1.1 |
% |
|
|
10,974 |
|
1.1 |
% |
|
|
21,376 |
|
1.1 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
160,946 |
|
17.8 |
% |
|
$ |
128,376 |
|
12.8 |
% |
|
$ |
289,322 |
|
15.2 |
% |
|
Fiscal Year Ended |
|||||||||||||||||||
|
Home &
|
|
Beauty &
|
|
Total |
|||||||||||||||
Operating income, as reported (GAAP) |
$ |
142,732 |
|
|
15.6 |
% |
|
$ |
117,857 |
|
|
10.8 |
% |
|
$ |
260,589 |
|
|
13.0 |
% |
Depreciation and amortization |
|
24,595 |
|
|
2.7 |
% |
|
|
26,904 |
|
|
2.5 |
% |
|
|
51,499 |
|
|
2.6 |
% |
Non-operating income, net |
|
— |
|
|
— |
% |
|
|
1,518 |
|
|
0.1 |
% |
|
|
1,518 |
|
|
0.1 |
% |
EBITDA (non-GAAP) |
|
167,327 |
|
|
18.3 |
% |
|
|
146,279 |
|
|
13.4 |
% |
|
|
313,606 |
|
|
15.6 |
% |
Add: Bed, Bath & Beyond bankruptcy |
|
3,087 |
|
|
0.3 |
% |
|
|
1,126 |
|
|
0.1 |
% |
|
|
4,213 |
|
|
0.2 |
% |
Gain on sale of distribution and office facilities |
|
(16,175 |
) |
|
(1.8 |
)% |
|
|
(18,015 |
) |
|
(1.7 |
)% |
|
|
(34,190 |
) |
|
(1.7 |
)% |
Restructuring charges |
|
5,144 |
|
|
0.6 |
% |
|
|
13,568 |
|
|
1.2 |
% |
|
|
18,712 |
|
|
0.9 |
% |
Non-cash share-based compensation |
|
16,319 |
|
|
1.8 |
% |
|
|
17,553 |
|
|
1.6 |
% |
|
|
33,872 |
|
|
1.7 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
175,702 |
|
|
19.2 |
% |
|
$ |
160,511 |
|
|
14.7 |
% |
|
$ |
336,213 |
|
|
16.8 |
% |
Reconciliation of Non-GAAP Financial Measures – GAAP Net Income to EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization), Adjusted EBITDA and Adjusted EBITDA Margin (Non-GAAP) (1) |
||||||||||||
(Unaudited) (in thousands) |
||||||||||||
|
Three Months Ended Last Day of February, |
|||||||||||
|
2025 |
|
2024 |
|||||||||
Net income, as reported (GAAP) |
$ |
50,917 |
|
|
10.5 |
% |
|
$ |
42,734 |
|
8.7 |
% |
Interest expense |
|
13,999 |
|
|
2.9 |
% |
|
|
12,500 |
|
2.6 |
% |
Income tax (benefit) expense |
|
(62,531 |
) |
|
(12.9 |
)% |
|
|
11,995 |
|
2.5 |
% |
Depreciation and amortization |
|
14,198 |
|
|
2.9 |
% |
|
|
14,462 |
|
3.0 |
% |
EBITDA (non-GAAP) |
|
16,583 |
|
|
3.4 |
% |
|
|
81,691 |
|
16.7 |
% |
Add: Acquisition-related expenses |
|
3,035 |
|
|
0.6 |
% |
|
|
— |
|
— |
% |
Asset impairment charges |
|
51,455 |
|
|
10.6 |
% |
|
|
— |
|
— |
% |
Restructuring charges |
|
7,943 |
|
|
1.6 |
% |
|
|
3,850 |
|
0.8 |
% |
Non-cash share-based compensation |
|
5,326 |
|
|
1.1 |
% |
|
|
8,767 |
|
1.8 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
84,342 |
|
|
17.4 |
% |
|
$ |
94,308 |
|
19.3 |
% |
|
Fiscal Years Ended Last Day of February, |
||||||||||||
|
2025 |
|
2024 |
||||||||||
Net income, as reported (GAAP) |
$ |
123,751 |
|
|
6.5 |
% |
|
$ |
168,594 |
|
|
8.4 |
% |
Interest expense |
|
51,922 |
|
|
2.7 |
% |
|
|
53,065 |
|
|
2.6 |
% |
Income tax (benefit) expense |
|
(32,087 |
) |
|
(1.7 |
)% |
|
|
40,448 |
|
|
2.0 |
% |
Depreciation and amortization |
|
55,048 |
|
|
2.9 |
% |
|
|
51,499 |
|
|
2.6 |
% |
EBITDA (non-GAAP) |
|
198,634 |
|
|
10.4 |
% |
|
|
313,606 |
|
|
15.6 |
% |
Add: Acquisition-related expenses |
|
3,035 |
|
|
0.2 |
% |
|
|
— |
|
|
— |
% |
Asset impairment charges |
|
51,455 |
|
|
2.7 |
% |
|
|
— |
|
|
— |
% |
Bed, Bath & Beyond bankruptcy |
|
— |
|
|
— |
% |
|
|
4,213 |
|
|
0.2 |
% |
Gain on sale of distribution and office facilities |
|
— |
|
|
— |
% |
|
|
(34,190 |
) |
|
(1.7 |
)% |
Restructuring charges |
|
14,822 |
|
|
0.8 |
% |
|
|
18,712 |
|
|
0.9 |
% |
Non-cash share-based compensation |
|
21,376 |
|
|
1.1 |
% |
|
|
33,872 |
|
|
1.7 |
% |
Adjusted EBITDA (non-GAAP) |
$ |
289,322 |
|
|
15.2 |
% |
|
$ |
336,213 |
|
|
16.8 |
% |
Reconciliation of Non-GAAP Financial Measures – GAAP (Loss) Income and Diluted EPS to Adjusted Income and Adjusted Diluted EPS (Non-GAAP) (1) |
|||||||||||||||||||||||
(Unaudited) (in thousands, except per share data) |
|||||||||||||||||||||||
|
Three Months Ended |
||||||||||||||||||||||
|
(Loss) Income |
|
Diluted EPS |
||||||||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||||||||
As reported (GAAP) |
$ |
(11,614 |
) |
|
$ |
(62,531 |
) |
|
$ |
50,917 |
|
|
$ |
(0.51 |
) |
|
$ |
(2.73 |
) |
|
$ |
2.22 |
|
Acquisition-related expenses |
|
3,035 |
|
|
|
— |
|
|
|
3,035 |
|
|
|
0.13 |
|
|
|
— |
|
|
|
0.13 |
|
Asset impairment charges |
|
51,455 |
|
|
|
3,895 |
|
|
|
47,560 |
|
|
|
2.25 |
|
|
|
0.17 |
|
|
|
2.08 |
|
Intangible asset reorganization (6) |
|
— |
|
|
|
64,604 |
|
|
|
(64,604 |
) |
|
|
— |
|
|
|
2.82 |
|
|
|
(2.82 |
) |
Restructuring charges |
|
7,943 |
|
|
|
814 |
|
|
|
7,129 |
|
|
|
0.35 |
|
|
|
0.04 |
|
|
|
0.31 |
|
Subtotal |
|
50,819 |
|
|
|
6,782 |
|
|
|
44,037 |
|
|
|
2.22 |
|
|
|
0.30 |
|
|
|
1.92 |
|
Amortization of intangible assets |
|
5,269 |
|
|
|
812 |
|
|
|
4,457 |
|
|
|
0.23 |
|
|
|
0.04 |
|
|
|
0.19 |
|
Non-cash share-based compensation |
|
5,326 |
|
|
|
401 |
|
|
|
4,925 |
|
|
|
0.23 |
|
|
|
0.02 |
|
|
|
0.22 |
|
Adjusted (non-GAAP) |
$ |
61,414 |
|
|
$ |
7,995 |
|
|
$ |
53,419 |
|
|
$ |
2.68 |
|
|
$ |
0.35 |
|
|
$ |
2.33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
22,904 |
|
|
Three Months Ended |
|||||||||||||||||
|
Income |
|
Diluted EPS |
|||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
|||||||
As reported (GAAP) |
$ |
54,729 |
|
$ |
11,995 |
|
$ |
42,734 |
|
$ |
2.29 |
|
$ |
0.50 |
|
$ |
1.79 |
|
Restructuring charges |
|
3,850 |
|
|
49 |
|
|
3,801 |
|
|
0.16 |
|
|
— |
|
|
0.16 |
|
Subtotal |
|
58,579 |
|
|
12,044 |
|
|
46,535 |
|
|
2.45 |
|
|
0.50 |
|
|
1.95 |
|
Amortization of intangible assets |
|
4,467 |
|
|
628 |
|
|
3,839 |
|
|
0.19 |
|
|
0.03 |
|
|
0.16 |
|
Non-cash share-based compensation |
|
8,767 |
|
|
552 |
|
|
8,215 |
|
|
0.37 |
|
|
0.02 |
|
|
0.34 |
|
Adjusted (non-GAAP) |
$ |
71,813 |
|
$ |
13,224 |
|
$ |
58,589 |
|
$ |
3.01 |
|
$ |
0.55 |
|
$ |
2.45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
23,891 |
|
Fiscal Year Ended |
||||||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||||||
As reported (GAAP) |
$ |
91,664 |
|
$ |
(32,087 |
) |
|
$ |
123,751 |
|
|
$ |
3.97 |
|
$ |
(1.39 |
) |
|
$ |
5.37 |
|
Acquisition-related expenses |
|
3,035 |
|
|
— |
|
|
|
3,035 |
|
|
|
0.13 |
|
|
— |
|
|
|
0.13 |
|
Asset impairment charges |
|
51,455 |
|
|
3,895 |
|
|
|
47,560 |
|
|
|
2.23 |
|
|
0.17 |
|
|
|
2.06 |
|
|
|
— |
|
|
(6,045 |
) |
|
|
6,045 |
|
|
|
— |
|
|
(0.26 |
) |
|
|
0.26 |
|
Intangible asset reorganization |
|
— |
|
|
64,604 |
|
|
|
(64,604 |
) |
|
|
— |
|
|
2.80 |
|
|
|
(2.80 |
) |
Restructuring charges |
|
14,822 |
|
|
1,433 |
|
|
|
13,389 |
|
|
|
0.64 |
|
|
0.06 |
|
|
|
0.58 |
|
Subtotal |
|
160,976 |
|
|
31,800 |
|
|
|
129,176 |
|
|
|
6.98 |
|
|
1.38 |
|
|
|
5.60 |
|
Amortization of intangible assets |
|
18,875 |
|
|
2,798 |
|
|
|
16,077 |
|
|
|
0.82 |
|
|
0.12 |
|
|
|
0.70 |
|
Non-cash share-based compensation |
|
21,376 |
|
|
1,240 |
|
|
|
20,136 |
|
|
|
0.93 |
|
|
0.05 |
|
|
|
0.87 |
|
Adjusted (non-GAAP) |
$ |
201,227 |
|
$ |
35,838 |
|
|
$ |
165,389 |
|
|
$ |
8.72 |
|
$ |
1.55 |
|
|
$ |
7.17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
23,065 |
|
Reconciliation of Non-GAAP Financial Measures – GAAP Income and Diluted EPS to Adjusted Income and Adjusted Diluted EPS (Non-GAAP) (1) |
|||||||||||||||||||||||
(Unaudited) (in thousands, except per share data) |
|||||||||||||||||||||||
|
Fiscal Year Ended |
||||||||||||||||||||||
|
Income |
|
Diluted EPS |
||||||||||||||||||||
|
Before Tax |
|
Tax |
|
Net of Tax |
|
Before Tax |
|
Tax |
|
Net of Tax |
||||||||||||
As reported (GAAP) |
$ |
209,042 |
|
|
$ |
40,448 |
|
|
$ |
168,594 |
|
|
$ |
8.72 |
|
|
$ |
1.69 |
|
|
$ |
7.03 |
|
Bed, Bath & Beyond bankruptcy |
|
4,213 |
|
|
|
53 |
|
|
|
4,160 |
|
|
|
0.18 |
|
|
|
— |
|
|
|
0.17 |
|
Gain on sale of distribution and office facilities |
|
(34,190 |
) |
|
|
(8,787 |
) |
|
|
(25,403 |
) |
|
|
(1.43 |
) |
|
|
(0.37 |
) |
|
|
(1.06 |
) |
Restructuring charges |
|
18,712 |
|
|
|
234 |
|
|
|
18,478 |
|
|
|
0.78 |
|
|
|
0.01 |
|
|
|
0.77 |
|
Subtotal |
|
197,777 |
|
|
|
31,948 |
|
|
|
165,829 |
|
|
|
8.25 |
|
|
|
1.33 |
|
|
|
6.92 |
|
Amortization of intangible assets |
|
18,326 |
|
|
|
2,447 |
|
|
|
15,879 |
|
|
|
0.76 |
|
|
|
0.10 |
|
|
|
0.66 |
|
Non-cash share-based compensation |
|
33,872 |
|
|
|
2,110 |
|
|
|
31,762 |
|
|
|
1.41 |
|
|
|
0.09 |
|
|
|
1.33 |
|
Adjusted (non-GAAP) |
$ |
249,975 |
|
|
$ |
36,505 |
|
|
$ |
213,470 |
|
|
$ |
10.43 |
|
|
$ |
1.52 |
|
|
$ |
8.91 |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Weighted average shares of common stock used in computing diluted EPS |
|
|
23,970 |
|
Selected Consolidated Balance Sheet and Cash Flow Information |
|||||
(Unaudited) (in thousands) |
|||||
|
Last Day of February, |
||||
|
2025 |
|
2024 |
||
Balance Sheet: |
|
|
|
||
Cash and cash equivalents |
$ |
18,867 |
|
$ |
18,501 |
Receivables, net |
|
428,330 |
|
|
394,536 |
Inventory |
|
452,615 |
|
|
395,995 |
Total assets, current |
|
931,712 |
|
|
843,918 |
Total assets |
|
3,132,083 |
|
|
2,838,622 |
Total liabilities, current |
|
466,259 |
|
|
450,811 |
Total long-term liabilities |
|
982,385 |
|
|
750,369 |
Total debt |
|
916,894 |
|
|
665,671 |
Stockholders' equity |
|
1,683,439 |
|
|
1,637,442 |
|
Fiscal Years Ended Last Day of February, |
|||||
|
2025 |
|
2024 |
|||
Cash Flow: |
|
|
|
|||
Depreciation and amortization |
$ |
55,048 |
|
$ |
51,499 |
|
Net cash provided by operating activities |
|
113,213 |
|
|
306,067 |
|
Capital and intangible asset expenditures |
|
30,072 |
|
|
36,644 |
|
Net debt proceeds (repayments) |
|
249,900 |
|
|
(269,076 |
) |
Payments for repurchases of common stock |
|
103,188 |
|
|
55,222 |
|
Reconciliation of Non-GAAP Financial Measures – GAAP Net Cash Provided by Operating Activities to Free Cash Flow (Non-GAAP) (1) (2) |
|||||||
(Unaudited) (in thousands) |
|||||||
|
Fiscal Years Ended Last Day of February, |
||||||
|
|
2025 |
|
|
|
2024 |
|
Net cash provided by operating activities (GAAP) |
$ |
113,213 |
|
|
$ |
306,067 |
|
Less: Capital and intangible asset expenditures |
|
(30,072 |
) |
|
|
(36,644 |
) |
Free cash flow (non-GAAP) |
$ |
83,141 |
|
|
$ |
269,423 |
|
Reconciliation of Non-GAAP Financial Measures – Net Leverage Ratio (Non-GAAP) (1) (3) |
|||
(Unaudited) (in thousands) |
|||
|
|||
|
Fiscal Year Ended
|
||
Adjusted EBITDA (non-GAAP) (13) |
$ |
289,322 |
|
Pro forma effect of the Olive & June acquisition (3) |
|
16,760 |
|
Adjusted EBITDA per the credit agreement |
$ |
306,082 |
|
|
|
||
Total borrowings under the credit agreement, as reported (GAAP) |
$ |
921,850 |
|
Add: Outstanding letters of credit |
|
9,460 |
|
Less: Unrestricted cash and cash equivalents |
|
(23,809 |
) |
Net debt |
$ |
907,501 |
|
|
|
||
Net leverage ratio (non-GAAP) (3) |
|
2.96 |
|
HELEN OF TROY LIMITED AND SUBSIDIARIES
Notes to Press Release
(1) |
|
This press release contains non-GAAP financial measures. Adjusted Operating Income, Adjusted Operating Margin, Adjusted Income, Adjusted Diluted EPS, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Net Leverage Ratio (“Non-GAAP Financial Measures”) that are discussed in the accompanying press release or in the preceding tables may be considered non-GAAP financial measures as defined by SEC Regulation G, Rule 100. Accordingly, the Company is providing the preceding tables that reconcile these measures to their corresponding GAAP-based financial measures. The Company is unable to present a quantitative reconciliation of forward-looking expected net leverage ratio to its most directly comparable forward-looking GAAP financial measure because such information is not available, and management cannot reliably predict all of the necessary components of such GAAP financial measure without unreasonable effort or expense. In addition, the Company believes such reconciliation would imply a degree of precision that would be confusing or misleading to investors. The Company believes that these Non-GAAP Financial Measures provide useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations. The Company believes that these Non-GAAP Financial Measures, in combination with the Company's financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of certain charges and benefits on applicable income, margin and earnings per share measures. The Company also believes that these Non-GAAP Financial Measures reflect the operating performance of its business and facilitate a more direct comparison of the Company's performance with its competitors. The material limitation associated with the use of the Non-GAAP Financial Measures is that the Non-GAAP Financial Measures do not reflect the full economic impact of the Company's activities. These Non-GAAP Financial Measures are not prepared in accordance with GAAP, are not an alternative to GAAP financial measures, and may be calculated differently than non-GAAP financial measures disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP financial measures. |
|
|
|
(2) |
|
Free cash flow represents net cash provided by operating activities less capital and intangible asset expenditures. |
|
|
|
(3) |
|
Net leverage ratio is calculated as (a) total borrowings under the Company's credit agreement plus outstanding letters of credit, net of unrestricted cash and cash equivalents, including readily marketable obligations issued, guaranteed or insured by the |
|
|
|
(4) |
|
Organic business refers to net sales revenue associated with product lines or brands after the first twelve months from the date the product line or brand is acquired, excluding the impact that foreign currency remeasurement had on reported net sales revenue. Net sales revenue from internally developed brands or product lines is considered Organic business activity. |
|
|
|
(5) |
|
On |
|
|
|
(6) |
|
Represents a transitional income tax benefit resulting from the recognition of a deferred tax asset in connection with the reorganization of the Company's intangible assets (“intangible asset reorganization”). |
|
|
|
(7) |
|
Non-cash asset impairment charges were recognized, during the fourth quarter of fiscal 2025, to reduce the goodwill and definite-lived trade name of the Company's |
|
|
|
(8) |
|
Accounts receivable turnover uses 12 months trailing net sales revenue. The current and four prior quarters' ending balances of trade accounts receivable are used for the purposes of computing the average balance component as required by the particular measure. |
|
|
|
(9) |
|
Domestic net sales revenue includes net sales revenue from the |
|
|
|
(10) |
|
Represents a charge for uncollectible receivables due to the bankruptcy of Bed, Bath & Beyond (“Bed, Bath & Beyond bankruptcy”). |
|
|
|
(11) |
|
Gain on the sale of distribution and office facilities in |
|
|
|
(12) |
|
Represents a discrete tax charge to revalue existing deferred tax liabilities as a result of |
|
|
|
(13) |
|
See reconciliation of Adjusted EBITDA to the most directly comparable GAAP-based financial measure (net income) in the accompanying tables to this press release. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250424847270/en/
Investor Contact:
(915) 225-4841
(203) 682-8200
Source: